-transparent.png){kind=logo}
Severity of withdrawal symptoms and clinical outcome were compared in 19 elderly and 22 younger benzodiazepine-dependent patients matched for benzodiazepine half-life, dosage, and duration of treatment. During gradual taper of benzodiazepine doses, the elderly patients showed significantly less severe withdrawal symptoms on several clinical measures and a comparably favorable outcome. Approximately half of each group remained benzodiazepine free for at least 4 weeks. Both groups of patients tolerated drug discontinuation without serious consequences such as seizures or psychosis. Tapered benzodiazepine withdrawal did not appear to be more risky for the elderly group than for the younger patients.
E Schweizer, and
W G Case, and
K Rickels
January 1983,
Maryland state medical journal,
E Schweizer, and
W G Case, and
K Rickels
January 1983,
Journal of psychoactive drugs,
E Schweizer, and
W G Case, and
K Rickels
September 1989,
The American journal of psychiatry,
E Schweizer, and
W G Case, and
K Rickels
January 1998,
International journal of psychiatry in clinical practice,
E Schweizer, and
W G Case, and
K Rickels
August 1993,
Drug safety,
E Schweizer, and
W G Case, and
K Rickels
January 1990,
Postgraduate medical journal,
E Schweizer, and
W G Case, and
K Rickels
November 2009,
Annales pharmaceutiques francaises,
E Schweizer, and
W G Case, and
K Rickels
November 1986,
Lancet (London, England),
E Schweizer, and
W G Case, and
K Rickels
January 1992,
The Journal of the American Board of Family Practice,
E Schweizer, and
W G Case, and
K Rickels
January 2002,
Psychiatria polska,
